Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Treatment ‘Life-Changing’ for Brockton Brothers
Emmanuel “Manny” Johnson, 21, of Brockton was the first patient to participate in a novel sickle cell clinical trial at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center — taking the risk for the sake of his little brother, who has the same disease.
Staying at the hospital for five or six hours every month for a blood transfusion was something that Johnson described as “a regular thing.” He had been receiving transfusions since he was 4-years-old after sickle cell caused him to have two mild strokes.
Now, Johnson hasn’t had a transfusion in nine months, thanks to the clinical trial. The trial wasn’t easy, but one thing motivated Johnson to stay strong — his 7-year-old brother, Aiden, who also has sickle cell disease.
+myBinderRelated Content
-
Living With Sickle Cell: ‘I Don’t Know What It Means to Be Without Pain’Once a month, she undergoes a grueling p...
-
Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (...BACKGROUND: Little is known about red b...
-
Gainey Raises Awareness About Sickle Cell, Fights For More Fundinghttps://www.youtube.com/watch?v=X9LuLJ7B...
-
Cure Sickle Cell FoundationCure Sickle Cell Foundation, Inc. is a 5...
-
Citizens for Quality Sickle Cell CareThe New England Sickle Cell Institute at...
-
Sickle Cell Disease isn’t Laughable, But It Has a Comedic Ambassador — Kier “Junior” SpatesMr. Spates believes in living a full lif...
-
Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care“You’re too pretty to have a disease...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.